Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-15

FDA Approved: IPRATROPIUM BROMIDE — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved the original application for ipratropium bromide from Advagen Pharma Ltd, granting a generic approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

ORIG AP for IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)